Amrize Ltd (NYSE:AMRZ) Receives $58.67 Average PT from Analysts

Amrize Ltd (NYSE:AMRZ) has received an average recommendation of “Hold” from the seven ratings firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $58.25.

Several brokerages have recently issued reports on AMRZ. JPMorgan Chase & Co. lifted their target price on Amrize from $52.00 to $60.00 and gave the stock an “overweight” rating in a report on Tuesday, August 26th. Wells Fargo & Company began coverage on Amrize in a report on Tuesday. They issued an “overweight” rating and a $57.00 target price on the stock. Oppenheimer began coverage on Amrize in a report on Tuesday, September 9th. They issued an “outperform” rating and a $62.00 target price on the stock. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Amrize in a report on Wednesday. Finally, Zacks Research cut Amrize from a “hold” rating to a “strong sell” rating in a report on Wednesday, August 27th.

Insider Transactions at Amrize

In related news, CTO Roald Brouwer purchased 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 27th. The stock was bought at an average price of $51.88 per share, for a total transaction of $103,760.00. Following the completion of the transaction, the chief technology officer owned 5,000 shares in the company, valued at approximately $259,400. The trade was a 66.67% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Stephen S. Clark purchased 5,000 shares of the company’s stock in a transaction that occurred on Friday, August 15th. The stock was bought at an average price of $51.82 per share, with a total value of $259,100.00. Following the transaction, the insider owned 5,000 shares of the company’s stock, valued at $259,100. This represents a ∞ increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 1,124,000 shares of company stock valued at $53,225,260.

Hedge Funds Weigh In On Amrize

Hedge funds have recently made changes to their positions in the company. BNP Paribas Financial Markets acquired a new position in shares of Amrize in the 2nd quarter valued at $59,000. Groupe la Francaise acquired a new position in shares of Amrize in the 2nd quarter valued at $60,000. Allianz SE acquired a new position in shares of Amrize in the 2nd quarter valued at $80,000. Osaic Holdings Inc. purchased a new stake in Amrize in the second quarter valued at $90,000. Finally, Credit Industriel ET Commercial purchased a new stake in Amrize in the second quarter valued at $109,000.

Amrize Price Performance

NYSE:AMRZ opened at $48.09 on Tuesday. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 0.42. The firm’s 50-day simple moving average is $50.78. Amrize has a 52 week low of $44.12 and a 52 week high of $56.29.

Amrize (NYSE:AMRZ) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $0.78 EPS for the quarter, missing analysts’ consensus estimates of $1.03 by ($0.25).

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.